Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes

PETHEMA Foundation · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
multiple myeloma in relapse, relapsed refractory multiple myeloma, elranatamab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 917435
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.